P B Timmermans

Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors.

J. Jaén, J. Medina, B. Shan, 1999, Proceedings of the National Academy of Sciences of the United States of America.